Opioid-based medications remain the most common in US clinical practice for the management of acute and chronic pain. While the opioid signalling system includes several endogenous receptors (μ, δ, and κ), most opioid analgesics target the μ opioid receptor (μOR). However, while activation of the μOR can lead to effective relief of acute pain, its […]

The post Investigating CBD as a Negative Allosteric Modulator of the μ‐Opioid Receptor appeared first on Sapphire Medical Clinics.